文献速递甲状腺与颈部外科围术期管理与 ERAS

继发性甲状旁腺功能亢进外科治疗策略的演变

[Evolution of surgical strategies for secondary hyperparathyroidism].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2026-10-29

本文综述了继发性甲状旁腺功能亢进(SHPT)外科治疗策略的演变,指出既往以PTH控制为核心的策略在手术患者筛选和多学科沟通中发挥重要作用,随着CKD-MBD理念发展,外科治疗目标已拓展至改善骨代谢、缓解症状、控制靶器官损害及改善长期结局,并围绕外科评估时机、手术指征、术式选择、围手术期管理和术后随访等探讨了策略演变及未来优化方向。

要点

  • SHPT外科治疗目标已从单纯降低PTH拓展至改善骨代谢、缓解症状及控制靶器官损害。
  • 既往基于PTH阈值和药物反应的手术筛选策略有历史作用但存在局限。
  • 外科评估时机、手术指征、术式选择及围手术期管理需结合指南共识综合决策。

核心结论

  • SHPT外科治疗策略已由单纯PTH控制转向以改善骨代谢、缓解症状、控制CKD-MBD相关靶器官损害及改善长期结局为目标。

研究设计与样本

  • 本文为综述,结合现有指南、共识和临床研究进行论述。

主要发现

  • 基于PTH阈值和药物反应的策略在手术患者筛选和多学科沟通中发挥过重要作用。
  • 随着CKD-MBD理念发展及临床结局证据积累,外科治疗目标逐步拓展。

临床怎么用

  • 临床应综合评估外科评估时机、手术指征、术式选择、围手术期管理和术后随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Secondary hyperparathyroidism (SHPT) is an important component of chronic kidney disease-mineral and bone disorder (CKD-MBD). It may be accompanied by bone pain, pruritus, abnormalities in bone metabolism, and vascular and soft-tissue calcifications, thereby increasing the disease burden in patients with end-stage kidney disease. Historically, surgical management of SHPT was mainly based on persistently elevated parathyroid hormone (PTH) levels and patients' responses to medical therapy, gradually establishing a management strategy centered on PTH control. This strategy has played an important role in selecting candidates for surgery and facilitating multidisciplinary communication. With the evolution of the CKD-MBD concept and accumulating evidence on clinical outcomes, the goals of surgical treatment have gradually expanded from merely lowering PTH levels to improving bone metabolism, relieving symptoms, controlling CKD-MBD-related target-organ damage, and improving long-term outcomes. Based on current guidelines, expert consensus, and clinical studies, this review discusses the historical basis and limitations of PTH threshold-based strategies and examines the evolution of surgical management for SHPT, with particular emphasis on the timing of surgical evaluation, surgical indications, choice of surgical procedure, perioperative management, postoperative follow-up, and future directions for optimization. 继发性甲状旁腺功能亢进(SHPT)是慢性肾脏病矿物质与骨异常(CKD-MBD)的重要组成部分,可伴有骨痛、皮肤瘙痒、骨代谢指标异常,以及血管和软组织钙化等临床表现,进而加重终末期肾病患者的疾病负担。既往SHPT的外科诊疗主要依据持续升高的甲状旁腺激素(PTH)及患者对药物的治疗反应,逐步形成以PTH控制为核心的诊疗策略,该策略在手术患者筛选和多学科沟通中发挥了重要作用。随着CKD-MBD理念的发展及临床结局证据的积累,外科治疗目标已由单纯降低PTH,逐步拓展至改善骨代谢、缓解症状、控制CKD-MBD相关靶器官损害及改善长期结局。本文结合现有指南、共识和临床研究,论述了PTH阈值模式的历史依据及局限,并围绕外科评估时机、手术指征、术式选择、围手术期管理和术后随访等问题,探讨了SHPT外科诊疗策略的演变及未来优化方向。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zheng X, Zhou L, Ou XH, et al. [Evolution of surgical strategies for secondary hyperparathyroidism]. Zhonghua Wai Ke Za Zhi. 2026. PMID: 42951844. doi:10.3760/cma.j.cn112139-20260521-00210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。